Fong, Youyi
McDermott, Adrian B. http://orcid.org/0000-0003-0616-9117
Benkeser, David http://orcid.org/0000-0002-1019-8343
Roels, Sanne
Stieh, Daniel J.
Vandebosch, An
Le Gars, Mathieu
Van Roey, Griet A.
Houchens, Christopher R.
Martins, Karen
Jayashankar, Lakshmi
Castellino, Flora
Amoa-Awua, Obrimpong
Basappa, Manjula
Flach, Britta
Lin, Bob C.
Moore, Christopher
Naisan, Mursal
Naqvi, Muhammed
Narpala, Sandeep
O’Connell, Sarah
Mueller, Allen
Serebryannyy, Leo
Castro, Mike http://orcid.org/0000-0002-8045-1754
Wang, Jennifer
Petropoulos, Christos J. http://orcid.org/0000-0001-5496-8090
Luedtke, Alex
Hyrien, Ollivier
Lu, Yiwen
Yu, Chenchen
Borate, Bhavesh
van der Laan, Lars W. P.
Hejazi, Nima S. http://orcid.org/0000-0002-7127-2789
Kenny, Avi
Carone, Marco http://orcid.org/0000-0003-2106-0953
Wolfe, Daniel N.
Sadoff, Jerald
Gray, Glenda E.
Grinsztejn, Beatriz
Goepfert, Paul A.
Little, Susan J.
Paiva de Sousa, Leonardo http://orcid.org/0000-0001-9004-5154
Maboa, Rebone
Randhawa, April K. http://orcid.org/0000-0003-2652-3734
Andrasik, Michele P.
Hendriks, Jenny
Truyers, Carla
Struyf, Frank http://orcid.org/0000-0001-9988-0260
Schuitemaker, Hanneke http://orcid.org/0000-0001-8563-2266
Douoguih, Macaya http://orcid.org/0000-0002-2707-5729
Kublin, James G.
Corey, Lawrence http://orcid.org/0000-0002-2179-2436
Neuzil, Kathleen M. http://orcid.org/0000-0001-9480-2714
Carpp, Lindsay N. http://orcid.org/0000-0003-0333-5925
Follmann, Dean http://orcid.org/0000-0003-4073-0393
Gilbert, Peter B. http://orcid.org/0000-0002-2662-9427
Koup, Richard A.
Donis, Ruben O.
,
,
,
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (UM1 AI068614, UM1 AI068635, R37AI054165)
Article History
Received: 29 June 2022
Accepted: 4 October 2022
First Online: 10 November 2022
Competing interests
: All authors have completed the ICMJE uniform disclosure form atExternalRef removedand declare that: P.B.G., Y.F., D.B., A.L., O.H., Y.L., C.Y., B.B., L.W.P.v.d.L., A.K., M.C., A.K.R., M.P.A., J.G.K., L.C. and L.N.C. had support (in the form of grant payments to their respective institutions) from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health for the submitted work; O.A.-A. had support from the NIH Vaccine Immunology Program for the submitted work; C.J.P. had support from Department of Health and Human Services Biomedical Advanced Research and Development Authority (BARDA) for the contract testing provided by Labcorp-Monogram Biosciences for the submitted work and is a shareholder in and corporate officer of Labcorp; A.L. declares support (in the form of grant payments to his institution) within the past 36 months from Janssen Pharmaceuticals for work on the HVTN 706 HIV vaccine efficacy trial and from the World Health Organization for writing the statistical analysis plan for the WHO’s Solidarity Trial for COVID-19 vaccines, as well as consulting fees within the past 36 months received from Harvard Medical School for statistical consulting on individualized medicine software; O.H. had support (in the form of payments to his institution) from the Bill and Melinda Gates Foundation within the past 36 months; N.S.H. had support (in the form of payments to his institution) from the National Science Foundation for the submitted work; S.R., D.J.S. and G.A.V.R. had partial support from the Department of Health and Human Services BARDA (in the form of contract payments to their respective institution) for the submitted work, has stock and/or stock options in Johnson & Johnson, and are employees of Janssen; A.V. had partial support from BARDA (in the form of contract payments to her institution) for the submitted work, had all patent rights transferred to Johnson & Johnson, has stock and/or stock options in Johnson & Johnson, and is an employee of Janssen; M.L.G. had partial support from BARDA (in the form of contract payments to his institution) for the submitted work, has shares in Johnson & Johnson, and is an employee of Johnson & Johnson; M.C. declares an honorarium from Pfizer within the past 36 months for serving on a scientific panel to evaluate submitted funding proposals on use of talazoparib in prostate cancer, submitted in response to a joint call by the National Comprehensive Cancer Network and Pfizer; J.S. declares support for the submitted work from the Janssen Pharmaceutical Companies of Johnson & Johnson and partial support (in the form of funding to his institution) from BARDA for the submitted work, declares support within the past 36 months from the Janssen Pharmaceutical Companies of Johnson & Johnson and BARDA funding for part of this work, has patents on invention of the Janssen COVID-19 vaccine, and has Johnson & Johnson stock and stock options; G.E.G. declares payment for speaking at a Johnson & Johnson-sponsored session at a conference within the past 36 months (payment donated to charity) and for serving on the Johnson & Johnson COVID-19 Vaccine Advisory Board (fees donated to charity), as well as receipt of 500,000 doses of Ad26.COV2.S vaccine donated by the United States Government/Johnson & Johnson for the Sisonke study; B.G. received consulting fees from Janssen within the past 36 months and declares receiving payments from Merck, Janssen and GSK within the last 36 months for participation on advisory boards, as well as receipt of Truvada provided to her institution from Gilead within the past 36 months for a PrEP demonstration project; P.A.G. declares support (in the form of grant payments to his institution) from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health within the past 36 months and consulting fees from Johnson & Johnson in the past 36 months; J.H. had partial support from BARDA (in the form of contract payments to her institution) for the submitted work, is a shareholder of Janssen Pharmaceuticals, and is an employee of Janssen Pharmaceuticals, C.T. had partial support from BARDA (in the form of contract payments to her institution) for the submitted work, holds stock in Janssen Pharmaceuticals, and is an employee of Janssen Pharmaceuticals; F.S. had partial support from BARDA (in the form of contract payments to his institution) for the submitted work, has restricted shares in Johnson & Johnson as part of compensation for employment, has shares in GlaxoSmithKline as compensation for past employment, and is employed by Johnson & Johnson; H.S. had partial support from BARDA (in the form of contract payments to her institution) for the submitted work, is a holder of Johnson & Johnson stock, and is an employee of Janssen Vaccines & Prevention BV; M.D. had partial support from BARDA (in the form of contract payments to her institution) for the submitted work, is a shareholder of Johnson & Johnson stock (has Johnson & Johnson Company stocks and stock options), and is an employee of Johnson & Johnson; K.M.N. declares grants paid to her institution within the past 36 months from Pfizer to conduct clinical trials of COVID vaccines (no salary support received from this grant) and support (in the form of grant payments to her institution) within the past 36 months from the National Institutes of Health; P.B.G. is a member of the BMGF COVID-19 Correlates Working Group (unpaid/no compensation); R.A.K. had support (in the form of intramural funding from NIAID) for the submitted work; R.O.D. declares that BARDA provided funding to Janssen and to Monogram Biosciences for the submitted work. All other authors declare no support from any organization for the submitted work, no financial relationships with any organizations that might have an interest in the submitted work in the previous 3 years, and no other relationships or activities that could appear to have influenced the submitted work.
: The COV3001 (ENSEMBLE) study was reviewed and approved by the following local ethics committees and Institutional Review Boards (IRBs): <b>Argentina:</b> ANMAT - Administración Nacional de Medicamentos, Alimentos y Tecnologia Médica (Capital Federal, La Plata, Ramos Mejia – Buenos Aires; Ciudad Autonoma de Buenos Aires), Comite de Etica Dr Carlos Barclay (Capital Federal, Buenos Aires; Ciudad Autonoma de Buenos Aires), Comision Conjunta de Investigacion en Salud – CCIS (La Plata, Ramos Mejia – Buenos Aires), Comite de Bioetica de Fundacion Huesped (Ciudad Autonoma de Buenos Aires), Comité de Docencia e Investigación DIM Clínica Privada (Ramos Mejia, Buenos Aires), Comité de Ética en Investigación Clínica y Maternidad Suizo Argentina (Ciudad Autonoma de Buenos Aires), Comité de Ética en Investigación de CEMIC (Ciudad Autonoma de Buenos Aires), Comite de Etica en Investigacion DIM Clinica Privada (Ramos Mejia, Buenos Aires), Comite de Etica Hospital Italiano de La Plata (La Plata, Buenos Aires), Comite de Etiica en Investigacion Hospital General de Agudos J.M. Ramos Mejia (Ciudad Autonoma de Buenos Aires), Comitéde ética del Instituto Médico Platense (CEDIMP) (La Plata, Buenos Aires), Institutional Biosafety Committee (IBC) Fundacion Huesped (Ciudad Autonoma de Buenos Aires), IBC Helios Salud (Ciudad Autonoma de Buenos Aires) and IBC Hospital General de Agudos J.M. Ramos Mejia (Ciudad Autonoma de Buenos Aires). <b>Brazil:</b> ANVISA – Agência Nacional de Vigilância Sanitária (Salvador, Bahia; Barretos, Campinas, São Paulo, São Jose Rio Preto, Ribeirão Preto, São Caetano do Sul – São Paulo; Santa Maria, Porto Alegre – Rio Grande do Sul; Natal, Rio Grande do Norte; Para, Pará; Belo Horizonte, Minas Gerais; Rio de Janeiro, Nova Iguaçu – Rio de Janeiro; Curitiba, Paraná; Brasília, Distrito Federal; Campo Grande, Mato Grosso do Sul; Criciúma, Santa Catarina; Cuiabá, Mato Grosso), CONEP - Comissão Nacional de Ética em Pesquisa (Salvador, Bahia; São Paulo, São Paulo; Santa Maria, Rio Grande do Sul; Para, Pará;), CAPPESq – Comissão de Ética de Análise para Projetos de Pesquisa – HCFMUSP (São Paulo, São Paulo), CEP da Faculdade de Medicina de São José do Rio Preto – FAMERP (São Jose Rio Preto, São Paulo), CEP da Faculdade de Medicina do ABC/SP (São Paulo, São Paulo), CEP da Fundação Pio XII - Hospital do Câncer de Barretos/SP (Barretos, São Paulo), CEP da Liga Norteriograndense Contra o Câncer (Natal, Rio Grande do Norte), CEP da Pontificia Universidade Catolica de Campinas / PUC Campinas (Campinas, São Paulo), CEP da Real Benemérita Associaçao Portuguesa de Beneficência - Hospital São Joaquim (São Paulo, São Paulo), CEP da Santa Casa de Misericórdia de Belo Horizonte (Belo Horizonte, Minas Gerais), CEP da Secretaria Municipal De Saúde do Rio de Janeiro – SMS/RJ (Rio de Janeiro, Rio de Janeiro), CEP da Universidade de São Caetano do Sul (CEP da Universidade de São Caetano do Sul, São Paulo), CEP da Universidade Federal de Mato Grosso do Sul – UFMS (Campo Grande, Mato Grosso do Sul), CEP da Universidade Federal de Minas Gerais (Belo Horizonte, Minas Gerais), CEP do Centro de Referência e Treinamento DST/AIDS (São Paulo, São Paulo), CEP do do INI-Ipec/Fiocruz (Rio de Janeiro, Rio de Janeiro), CEP do Grupo Hospitalar Conceição / RS (Porto Alegre, Rio Grande do Sul), CEP do Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto/USP (Ribeirão Preto, São Paulo), CEP do Hospital de Clinicas da Universidade Federal do Parana - HCUFPR / PR (Curitiba, Paraná), CEP do Hospital de Clínicas de Porto Alegre/HCPA (Porto Alegre, Rio Grande do Sul), CEP do Hospital Geral de Nova Iguaçu (Nova Iguaçu, Rio do Janeiro), CEP do Hospital Municipal São José (Criciúma, Santa Catarina), CEP do Hospital Pró-Cardíaco/RJ (Rio de Janeiro, Rio de Janeiro), CEP do Hospital Sírio Libanês (São Paulo, Sao Paulo), CEP do Hospital Universitário Júlio Muller / MT (Cuiabá, Mato Grosso), CEP do Hospital Universitário Professor Edgard Santos – UFBA (Salvador, Bahia), CEP do Instituto de Cardiologia do Distrito Federal (Brasília, Distrito Federal), CEP do Instituto de Infectologia Emílio Ribas/SP (São Paulo, Sao Paulo), CEP do Instituto de Saude e Bem Estar da Mulher - ISBEM / SP (São Paulo, Sao Paulo), CEP em Seres Humanos do HFSE - Hospital Federal dos Servidores do Estado (Rio de Janeiro, Rio de Janeiro), and CONEP - Comissão Nacional de Ética em Pesquisa (Brasília, Distrito Federal, Salvador, Bahia; Belo Horizonte, Minas Gerais; Cuiabá, Mato Grosso; Campo Grande, Mato Grosso do Sul; Nova Iguaçu, Rio Janeiro – Rio Janeiro; Barretos, Campinas, Sao Jose Rio Preto, São Caetano do Sul, Sao Paulo, Ribeirão Preto – Sao Paulo; Porto Alegre, Rio Grande do Sul; Natal, Rio Grande do Norte; Curitiba, Paraná; and Criciúma, Santa Catarina). <b>Chile:</b> Comité de Ética de Investigación en Seres Humanos (Santiago, Region Met), Comité Ético Científico Servicio de Salud Metropolitano Central (Santiago, Region Met), Instituto de Salud Pública de Chile (Santiago, Region Met; Talca, Temuco), Comité Ético Científico Servicio de Salud Metropolitano Sur Oriente (Talca, Santiago), Comité de Evaluación Ética Científica Servicio de Salud Araucanía Sur Temuco (Temuco) and Comité Ético Científico Servicio de Salud Metropolitano Central (Viña del Mar). <b>Colombia:</b> CEI de la Fundación Cardiovascular de Colombia (Floridablanca), Comité de Ética en Investigación Clínica de la Costa (Barranquilla), INVIMA - Instituto Nacional de Vigilancia de Medicamentos y Alimentos (Colombia) (Barranquilla), Comite de Etica en Investigacion de la E.S.E. Hospital Mental de Antioquia (Santa Marta), Comite de Etica en la Investigacion CAIMED (Bogotá), INVIMA - Instituto Nacional de Vigilancia de Medicamentos y Alimentos (Colombia) (Bogotá), Comite Corporativo de Etica en Investigacion de la Fundacion Santa Fe de Bogota (Bogotá), Comité de Ética e Investigación Biomédica de la Fundación Valle del Lili (Cali), Comite de Etica e Investigacion IPS Universitaria (Medellin), Comite de Etica en Investigacion Asustencial Cientifica de Alta Complejidad (Bogotá), Comite de Etica en Investigacion Biomedica de la Corporacion Cientifica Pediatrica de Cali (Cali), Comité de Ética en Investigación Clínica de la Costa (Barranquilla), Comite de Etica en Investigacion de la E.S.E. Hospital Mental de Antioquia (Barrio Barzal Villavicencio), Comite de Etica en Investigacion del area de la Salud de la Universidad del Norte (Barranquilla), Comite de Etica en Investigacion Medplus Centro de Recuperación Integral S.A.S (Bogotá), Comité de Ética en Investigaciones CEI-FOSCAL (Floridablanca), Comite de Etica en la Investigacion CAIMED (Bogotá), Comite de Etica para Investigacion Clinica(CEIC) de la Fundacion Centro de Investigacion Clinica CIC (Medellin) and Comite de Investigaciones y Etica en Investigaciones Hospital Pablo Tobon Uribe (Medellin), and INVIMA - Instituto Nacional de Vigilancia de Medicamentos y Alimentos (Colombia) (Barranquilla, Bogotá, Cali, Floridablanca, Medellin). <b>Mexico:</b> CEI del Hospital Civil de Guadalajara Fray Antonio Alcalde (Guadalajara, Jalisco), CEI Hospital La Mision (Tijuana, Baja California Norte), CI del Hospital Civil de Guadalajara Fray Antonio Alcalde (Guadalajara, Jalisco), CI Hospital La Mision (Tijuana, Baja California Norte), Comite de Bioseguridad del Instituto Nacional de Salud Publica (Mexico, Distrito Federal; Cuernavaca, Morelos), Comite de Etica en Investigacion del Instituto Nacional de Salud Publica (Mexico, Distrito Federal; Cuernavaca, Morelos), Comité de Bioseguridad del Hospital La Misión S.A. de C.V. (Tijuana, Baja California Norte; Oaxaca, Oaxaca; Merida, Yucatán; Tijuana, Baja California Norte), Comité de Bioseguridad de la Coordinación de Investigación en Salud (IMSS) (Mexico, Estado de Mexico), Comité de Bioseguridad de Médica Rio Mayo (CLINBOR) (Mexico, Distrito Federal), Comité de Bioseguridad del Hospital Universitario ‘Dr José Eleuterio González’ (Monterrey, Nuevo León), COFEPRIS (Comisión Federal para la Protección contra Riesgos Sanitarios) (Cuernavaca, Morelos; Mexico, Distrito Federal; Monterrey, Nuevo León; Oaxaca, Oaxaca; Merida, Yucatán), Comite de Etica de la Fac de Med de la UANL y Hospital Universitario ‘Dr Jose Eleuterio Gonzalez’ (Monterrey, Nuevo León), Comite de Etica en Investigacion de la Unidad de Atencion Medica e Investigacion en Salud S.C. (Merida, Yucatán), Comite de Etica en Investigacion de Medica Rio Mayo S.C. (Mexico, Distrito Federal), Comite de Etica en Investigacion de Oaxaca Site Management Organization, S.C. (Oaxaca, Oaxaca), Comite de Etica en Investigacion del Centro Medico Nacional Siglo XXI (IMSS) (Mexico, Estado do Mexico), Comité de Investigación de la Coordinación de Investigación en Salud (IMSS) (Mexico, Estado do Mexico), Comite de Investigacion de la Unidad de Atencion Medica e Investigacion en Salud S.C. (Merida, Yucatán), Comite de Investigacion de Oaxaca Site Management Organization, S.C. (Oaxaca, Oaxaca), Comité de Investigación del Hospital Universitario José Eleuterio González (Monterrey, Nuevo León) and Comite de Investigacion Medica Rio Mayo, S.C. (Mexico, Distrito Federal). <b>Peru:</b> Comite Nacional Transitorio de Etica en Invest. de los Ensayos Clinicos de la enfermedad COVID-19 (Iquitos – Maynas, Loreto; Lima, San Miguel – Lima) and INS - Instituto Nacional de Salud (Peru) (Lima, San Miguel – Lima; Callao; Iquitos – Maynas, Loreto). <b>South Africa:</b> Department Agriculture, Forestry and Fisheries (DAFF) (Port Elizabeth, Mthatha – Eastern Cape; Cape Town, Worcester – Western Cape; Durban, Ladysmith, Vulindlela – KwaZulu-Natal; Johannesburg, Pretoria, Mamelodi East, Soweto, Tembisa – Gauteng; Rustenburg, Klerksdorp – North West; Bloemfontein, Free State; Middelburg, Mpumalanga; Dennilton, Limpopo), Pharma Ethics (Port Elizabeth, Eastern Cape; Durban, Ladysmith – KwaZulu-Natal; Cape Town, Western Cape; Pretoria, Mamelodi East, Johannesburg, Tembisa – Gauteng; Rustenburg, Klerksdorp – North West; Bloemfontein, Free State; Middelburg, Mpumalanga; Dennilton, Limpopo), SAHPRA - South African Health Products Regulatory Authority (Port Elizabeth, Mthatha – Eastern Cape; Cape Town, Worcester – Western Cape; Durban, Ladysmith, Vulindlela – KwaZulu-Natal; Johannesburg, Pretoria, Mamelodi East, Soweto, Tembisa – Gauteng; Rustenburg, Klerksdorp – North West; Bloemfontein, Free State; Middelburg, Mpumalanga; Dennilton, Limpopo), WIRB (Mamelodi East, Pretoria – Gauteng; Ladysmith, KwaZulu-Natal; Bloemfontein, Free State; Cape Town, Western Cape; Dennilton, Limpopo), Wits Health Consortium (Soweto, Johannesburg – Gauteng; Ladysmith, KwaZulu-Natal; Mthatha, Eastern Cape), Wits IBC (Soweto, Pretoria, Johannesburg, Tembisa – Gauteng; Rustenburg, Klerksdorp – North West; Mthatha, Eastern Cape), University of Cape Town HREC (Cape Town, Worcester – Western Cape); University of Cape Town Institute of Infectious Disease and Molecular Medicine (Cape Town, Worcester – Western Cape), University of Cape Town IBC (Cape Town, Worcester – Western Cape), SAMRC Human Research Ethics Committee Scientific Review (Durban, KwaZulu-Natal), Sefako Makgatho University Research Ethics Committee (SMUREC) (Pretoria, Gauteng), University of KwaZulu-Natal IBC (Durban, KwaZulu-Natal), University of KwaZulu-Natal Ethics (Durban, Vulindlela – KwaZulu-Natal), University of Stellenbosch Ethics Committee (Cape Town, Western Cape) and University of KwaZulu-Natal IBC (Vulindlela, KwaZulu-Natal). <b>United States:</b> Advarra IBC (Detroit, MI; Chapel Hill, NC; Boston, MA; Seattle, WA; Winston-Salem, NC; Austin, TX; Peoria, IL; Huntsville, AL; Long Beach, CA; Tucson, AZ), Biomedical Institute of New Mexico IBC (Albuquerque, NM), Birmingham VA Medical Center – Alabama IBC (Birmingham, AL), Clinical Biosafety Services (Hollywood, FL), Columbia University IBC (New York, NY), Copernicus Group IRB (Austin, Dallas, Houston, San Antonio – TX; Rochester, New York, Bronx, Binghamton – NY; Hillsborough, Hackensack, Newark, New Brunswick – NJ; West Palm Beach, Coral Gables, Hollywood, Miami, Orlando, Gainesville, Tampa, Hallandale Beach, Pinellas Park, The Villages, Jacksonville, Deland – FL; Fort Worth, Dallas, San Antonio – TX; Norfolk, Charlottesville – VA; Matairie, New Orleans – LA; Nashville, Knoxville, Memphis, Bristol – TN; Cincinnati, Cleveland, Columbus, Akron – OH; Detroit, Ann Arbor, Grand Rapids – MI; Philadelphia, Pittsburgh – PA; Stanford, San Diego, San Francisco, Oakland, Long Beach, Anaheim, Sacramento, West Hollywood – CA, Las Vegas, Reno – NV; Chicago, Peoria – IL; Omaha, NE; Mobile, Birmingham, Huntsville – AL; St Louis, Greer, Kansas City – MO; Boston, MA; Harrisburg, SD; Decatur, Atlanta, Savannah – GA; Baltimore, Rockville, Annapolis – MD; New Haven, Hartford – CT; Chapel Hill, Raleigh, Fayetteville, Charlotte, Durham, Winston-Salem – NC; Indianapolis, Valparaiso, Evansville – IN; Seattle, WA; Aurora, CO; Lexington, Louisville – KY; Murray, West Jordan, Salt Lake City – UT; Phoenix, Tucson, Glendale – AZ; Spartanburg, Columbia, North Charleston, Anderson, Charleston, Mount Pleasant – SC; Portland, Medford, Corvallis – OR; Albuquerque, Gallup – NM; Little Rock, AR; Jackson, MS; Newport News, VA, Minneapolis, MN; Lenexa, KS), WIRB (Hackensack, NJ; Dallas, TX; Baltimore, MD; Chicago, IL; Aurora, CO; Winston-Salem, NC; Minneapolis, MN; Orlando, Miami, Gainesville – FL; Philadelphia, Pittsburgh – PA; Boston, MA; St Louis, MO; Bronx, New York, NY; New Brunswick, NJ; Phoenix, AZ; Birmingham, AL; Louisville, KY; Albuquerque, NM; New Orleans, LA; Baltimore, MD; San Francisco, CA; Tampa, FL; Aurora, CO; Columbia, SC; Decatur, GA; Reno, NV; Raleigh, NC; Little Rock, AS), Clinical Biosafety Services (Dallas, San Antonio – TX; San Diego, CA; Lexington, KY; Murray, UT; Greer, Kansas City, St Louis – MO; Rockville, MD; Las Vegas, NV; Cincinnati, Columbus, Akron – OH; Phoenix, Tucson, Glendale – AZ; North Charleston, Anderson – SC; Orlando, Pinellas Park, The Villages, Miami – FL; Birmingham, AL; Valparaiso, Evansville – IN; Lenexa, KS), Columbia University IBC (Bronx, New York), Durham VA Medical Center IBC (Raleigh, NC), Emory University IRB (Decatur, GA), Environmental Health and Safety Office (Atlanta, GA), IBC (New Orleans, LA), James A. Haley Veterans Hospital IBC (Tampa, FL), Jesse Brown VA Medical Center IBC (Chicago, IL), Mass General Brigham IBC (Boston, MA), Mount Sinai- Icahn School of Medicine IBC (New York, NY), New York Blood Center IBC (New York, NY), OHSU IBC (Portland, OR), Partners IBC (Boston, MA), Rocky Mountain Regional VA Medical Center IBC (Aurora, CO), Rush University Medical Center (Chicago, IL), Rush University Medical Center IBC (Chicago, IL), Rutgers IBC (New Brunswick, NJ), Saint Louis University IBC (St Louis, MO), Saint Michael’s Medical Center IRB (Newark, NJ), Southeast Louisiana Veterans Health Care System IBC (New Orleans, LA), St. Jude Children’s Research Hospital IBC Committee (Memphis, TN), St. Jude Children’s Research Hospital IRB (Memphis, TN), Stanford University Administrative Panel on Human Subjects in Medical Research (Stanford, CA), Temple University IBC (Philadelphia, PA), The University of Chicago IBC (Chicago, IL), UAMS IBC (Little Rock, AS), UIC IBC (Chicago, IL), University of Alabama at Birmingham IBC (Birmingham, AL), University of Arkansas IRB (Little Rock, AS), University of Kentucky Biological Safety (Lexington, KY), University of Kentucky IRB (Lexington, KY), University of Louisville IRB (Louisville, KY), University of Miami IBC (Miami, FL), University of Mississippi Medical Center IRB (Jackson, MI), University of Pennsylvania IBC (Philadelphia, PA), University of Pittsburgh IBC (Pittsburgh, Pennsylvania), University of South Florida IRB (Tampa, FL), University of Utah IBC (Salt Lake City, UT), University of Utah IRB (Salt Lake City, UT), UTHealth IBC (Houston, TX), VA Baltimore Research and Education Foundation (BREF) IBC (Baltimore, MD), VA Central Arkansas Veterans Healthcare System IBC (Little Rock, AS), VA James J. Peters Department of VA Medical Center IBC (Bronx, NY), VA Medical Center – Atlanta IBC (Decatur, GA), VA Medical Center San Francisco IBC (San Francisco, CA), VA North Florida/South Georgia IBC (Gainesville, FL), VA North Texas Health Care System IBC (Dallas, TX), VA San Diego Healthcare System IBC (Phoenix, AZ), VA Sierra Nevada Health Care System IBC (Reno, NV), Vanderbilt University IRB (Nashville, TN), Washington University IBC (St Louis, MO), WCG IBCS (Houston, TX; Orlando, FL), Western IRB (San Diego, CA; Detroit, MI; New Orleans, LA; New York, NY), WIRB - IBCS Services (Chicago, IL; New Orleans, LA; Oakland, CA; Minneapolis, MN; Columbus, OH; Lexington, KY) and WJB Dorne VA Medical Center IBC (Columbia, SC).
Free to read: This content has been made available to all.